Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.

[1]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[2]  G. Schlimok,et al.  Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factors. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Braun,et al.  Micrometastatic bone marrow involvement: detection and prognostic significance , 1999, Medical oncology.

[4]  F. Wawroschek,et al.  Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy? , 1999, Urological Research.

[5]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[6]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[7]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A S Whittemore,et al.  Prostate cancer incidence and mortality in the United States and the United Kingdom. , 1998, Journal of the National Cancer Institute.

[9]  A. van Dalen,et al.  Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop , 1998, Tumor Biology.

[10]  I. Funke,et al.  Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Smart.  The results of prostate carcinoma screening in the U. S. As reflected in the surveillance, epidemiology, and end results program , 1997 .

[12]  S. Braun,et al.  Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.

[13]  K. Pantel,et al.  Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. , 1996, Journal of the National Cancer Institute.

[14]  K. Pantel,et al.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases , 1996, The Lancet.

[15]  G. Bastert,et al.  56. Long-term follow-up of breast cancer patients with micrometastatic tumour cells in bone marrow at primary surgery — prognostic impact in comparison to nodal status , 1995 .

[16]  G. Schlimok,et al.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients , 1992, The Lancet.

[17]  J. Witte,et al.  Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[22]  J. Siewert,et al.  Detection of micrometastasis in bone marrow of pancreatic cancer patients. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[24]  J. Izbicki,et al.  Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. , 1994, Journal of hematotherapy.

[25]  J. Bingham.  Letter: Lower oesophageal sphincter. , 1974, Lancet.

[26]  D. Cox.  Regression Models and Life-Tables , 1972 .